#Germany #Fresenius Medical Care #Bad Homburg #TherapyWise™ #NxStage® System One™

Innovating Kidney Replacement Therapy with TherapyWise™

Fresenius Medical Care, the world's premier provider of renal disease-related products and services, has recently launched TherapyWise™, a cloud-based analytics solution aimed at improving kidney replacement therapy (KRT) within critical care environments. Featured within the NXStage® System One™, TherapyWise™ leverages the NxView™ 4.0 software platform, which has received FDA 510(k) clearance for use in the United States.

An Insightful Approach to KRT

Kidney replacement therapy, especially in the Intensive Care Unit (ICU), generates vast amounts of clinical and operational data. However, identifying trends in therapy delivery, workflow disruptions, and alarm rates can be challenging without proper aggregation and standardized metrics. TherapyWise™ addresses this gap by compiling data from the point of care into longitudinal summaries. This allows for effective management and oversight of KRT programs across various ICU units and timelines.

Joe Turk, the Chief Executive Officer of Care Enablement at Fresenius Medical Care, highlighted the significance of digital solutions in understanding complex therapies. He stated, "TherapyWise reflects our commitment to innovation by integrating data analytics into critical care. It enhances visibility for hospital leaders, enabling data-driven discussions on workflow consistency and quality improvement."

How TherapyWise™ Functions

TherapyWise™ operates by securely collecting data from the NxStage System One and transmitting it to a cloud-based platform, where it is aggregated and visualized according to established performance indicators. These indicators include:

• - Average delivered dose compared to the prescribed dose
• - Average treatment time per cartridge
• - Trends in alarm frequency

This framework is designed to facilitate retrospective analysis and program oversight, catering primarily to hospital and clinical leaders rather than delivering real-time, patient-specific clinical decisions.

Comprehensive Critical Care Portfolio

As part of Fresenius Medical Care’s NxView 4.0 and its comprehensive critical care offerings, TherapyWise™ combines digital infrastructure, clinical expertise, and secure data management. This integration serves as a critical resource for the healthcare teams managing kidney replacement therapy programs, ensuring they provide optimal care.

To explore more about TherapyWise™, visit Fresenius Medical Care's official website.

Fresenius Medical Care: A Leader in Renal Care

With over 4.5 million patients receiving dialysis treatment globally, Fresenius Medical Care operates a network of 3,539 dialysis clinics, serving approximately 290,000 patients worldwide. The organization stands at the forefront of dialysis products, including machines and dialyzers, and is traded on both the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).

As they continue to innovate and improve patient care in kidney treatment, Fresenius Medical Care exemplifies how technology and healthcare can effectively merge for enhanced patient outcomes.

Disclaimer

This article includes forward-looking statements subject to risks and uncertainties. Actual results may differ due to various factors, including changes in economic conditions and regulatory approvals. For a complete understanding of these risks, refer to Fresenius Medical Care's reports submitted to the U.S. Securities and Exchange Commission.

For media inquiries, contact:
Christine Peters
Email: [email protected]
Phone: +49 160 60 66 770
Kirsten Stratton
Email: [email protected]
Phone: +1 781 929 8096